Software & Services
Etherstack (ASX:ESK) is pleased to present commentary on activities in Q3 FY20 and up to the date of this report, to accompany the lodgement of this Appendix 4C cash report for the quarter ending 30 September 2020.
BetMakers Technology Group Holdings Limited (ASX:BET) (FRA:T07) is pleased to advise investors and shareholders that Managing Director, Todd Buckingham, will be presenting as part of the Broker Briefing Wagering Webinar on Friday 30 October 2020.
Etherstack plc (ASX:ESK) is pleased to announce that its North American subsidiary, Etherstack Inc. has successfully delivered and commissioned a digital radio network for the Royal Canadian Mounted Police (RCMP), the federal policing agency of Canada, within the Arctic Circle.
iSignthis Ltd (ASX:ISX) (FRA:TA8) is pleased to announce its 6th consecutive positive quarterly operating cash flow contained in the Appendix 4C and our quarterly business activity report.
ASX Ltd's (ASX:ASX) Disgraceful Conduct to Gain Commercial Advantage Against iSignthis Ltd (ASX:ISX)
ASX Ltd's (ASX:ASX) release today of selective extracts from outdated correspondence between an iSignthis Ltd's (ASX:ISX) EU subsidiary and Visa Europe Ltd is a disgraceful abuse of its privileged position as a licensed market operator.
Betmakers Technology Group Ltd (ASX:BET) (FRA:T07) has been focusing on shifting the commercial model for new products and new customers to be more aligned with its customers' financial performance - offering % of turnover or % of revenue deals giving customers flexibility with products and services.
NSX Limited (ASX:NSX), NSX Limited wishes to advise that the Company has been informed that the ASX Group has today made formal lodgement of the ASX Clear operating rules ("rules") to ASIC.
Etherstack plc's (ASX:ESK) UK based subsidiary has entered a technology licensing agreement with TPL Systemes, a French company designing and manufacturing radio communications equipment and solutions for the emergency services sector.
iSignthis Ltd (ASX:ISX) (FRA:TA8) is pleased to present to final half year accounts of the Company, post completion of the half year audit review.
Etherstack plc (ASX:ESK) advises of the implementation of the Etherstack Incentive Performance Rights Plan (Plan). To achieve its objectives, Etherstack and its group companies need to attract and retain key staff, management and Directors.
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Hillcrest Energy Technologies Ltd. (CNSX:HEAT) (OTCMKTS:HLRTF) - Ultra-Efficient Power Conversion - Ellis Martin Report with CEO Don Currie
- State Gas Limited (ASX:GAS) Quarterly Activities Report
- Central Petroleum Limited (ASX:CTP) Quarterly Activities Report
- Beetaloo Energy Australia Limited (ASX:BTL) Quarterly Activities Report
- Basin Energy Ltd (ASX:BSN) Quarterly Activities Report
- Central Petroleum Limited (ASX:CTP) Cooper and Otway Basin Transaction Completes
Life Sciences
- BPH Energy Limited (ASX:BPH) December 2025 Quarterly Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Canadian Patent Secured for PromarkerEso Test for Esophageal Adenocarcinoma
- Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of CEO and Managing Director
- BPH Energy Limited (ASX:BPH) Raises $1.2M to Accelerate Funding of Hydrocarbon and Cortical Investments
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer




























